Today, Idera Pharmaceuticals Inc (NASDAQ:IDRA) investors woke up to a nice pop in the value of their shares, after the drug maker presented …
AVEO Pharmaceuticals Shares Skyrocket on Positive CHMP Opinion It’s a very rewarding trading day for investors in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) with shares up over …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) is reporting additional data from the dose-escalation phase of its ongoing Phase 1/2 clinical trial of intratumoral IMO-2125, an agonist …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced the appointment of Jonathan Yingling, Ph.D.
This morning, Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced a licensing and collaboration agreement with Vivelix for rights to develop and market IMO-9200, a TLR …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) and Vivelix Pharmaceuticals, Ltd. announced that they have entered into an exclusive license and collaboration agreement granting Vivelix worldwide …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) is reporting translational data supporting the mechanism of action of intratumoral IMO-2125, a Toll-like receptor (TLR) 9 agonist from …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported its financial and operational results for the third quarter ended September 30, 2016. Since June 30, 2016, the Company: …
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced the pricing of an underwritten public offering of 25,000,000 shares of common stock for a public offering price of …
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced yesterday that it intends to offer and sell up to $50,000,000 of shares of its common stock in …